Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helminth voltage-gated calcium channels (VGCCs) are essential transmembrane proteins that mediate the entry of calcium ions into cells in response to changes in membrane potential (Greenberg, 2014, Frontiers in Genetics). In parasitic flatworms like Schistosoma mansoni, these channels play a fundamental role in coordinating motor activity, muscle contraction, and the integrity of the tegument, which is the parasite's primary interface with the host environment (Jeziorski & Greenberg, 2006, Molecular and Biochemical Parasitology). The helminth VGCC complex typically comprises a pore-forming alpha-1 subunit and regulatory subunits, including a unique beta subunit that has been a major focus of pharmacological research (Kohn et al., 2001, Parasitology). For many years, these channels were identified as the primary molecular target of praziquantel, the gold-standard treatment for schistosomiasis and other trematode infections (Greenberg, 2014, Frontiers in Genetics). Although recent studies have identified a specific transient receptor potential (TRP) channel as a high-affinity target for praziquantel, VGCCs remain vital to parasite calcium homeostasis and survival (Park & Marchant, 2019, Science). Pharmacological disruption of these channels causes a rapid, massive influx of calcium, leading to sustained muscular contraction and paralysis of the worm. This calcium surge also induces tegumental vacuolization, which exposes parasite-specific antigens to the host's immune system. Because helminth VGCCs, particularly the beta subunits, exhibit structural divergence from human orthologs, they provide a basis for selective anthelmintic toxicity (Kohn et al., 2001, Parasitology). Consequently, they remain a significant area of interest for developing new drugs to combat neglected tropical diseases.
Modulation of calcium ion influx through the channel complex, specifically involving the regulatory beta subunit, leading to rapid muscle contraction, paralysis, and tegumental disruption (Greenberg, 2014, Frontiers in Genetics; Kohn et al., 2001, Parasitology).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helminth voltage-gated calcium channel (VGCC).